Tilray shares soared in anticipation of marijuana rescheduling, but nothing changed, causing the stock to plummet. The company has consistently underperformed, down over 91% in five years. Despite hopes for a rally, Tilray’s stock continues to decline, highlighting the risks of investing in the volatile cannabis industry.

Read more at Yahoo Finance: Down 66% From Its High, Can Tilray Brands Stock Turn Things Around?